Thyroid eye disease following administration of the BNT162B2 COVID-19 vaccine

被引:2
作者
Fujita, H. [1 ]
Makino, S. [2 ,3 ]
Hasegawa, T.
Saima, Y. [4 ]
Tanaka, Y. [1 ]
Nagashima, S. [5 ]
Kakehashi, A. [1 ]
Kaburaki, T. [1 ,6 ]
机构
[1] Jichi Med Univ, Dept Ophthalmol, Saitama Med Ctr, Saitama, Saitama, Japan
[2] Inoda Eye Clin, Nasushiobara, Tochigi, Japan
[3] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan
[4] Nihon Univ, Div Ophthalmol, Itabashi Hosp, Itabashi Ku, Tokyo, Japan
[5] Jichi Med Univ, Dept Endocrinol & Metab, Saitama Med Ctr, Saitama, Saitama, Japan
[6] Jichi Med Univ, Dept Ophthalmol, Saitama Med Ctr, Saitama, Saitama 3308503, Japan
关键词
GRAVES-DISEASE; SARS-COV-2;
D O I
10.1093/qjmed/hcac265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:130 / 132
页数:3
相关论文
共 22 条
[21]   New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases [J].
Kan Chen ;
Yiyang Gao ;
Jing Li .
European Journal of Medical Research, 28
[22]   Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination [J].
Taskaldiran, Isilay ;
Altay, Feride Pinar ;
Bozkus, Yusuf ;
Iyidir, Ozlem Turhan ;
Nar, Asli ;
Tutuncu, Neslihan Bascil .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (03) :405-409